Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 8/20 | 0.42 |
| ▸ | NOS2 | P35228 | 3/20 | 0.40 |
| ▸ | NOS1 | P29475 | 2/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.40 |
| ▸ | ARG1 | P05089 | 1/20 | 0.37 |
| ▸ | ARG2 | P78540 | 1/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.36 |
| ▸ | BHMT | Q93088 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29888727 | 1.00 | KIF11 (0.42) | KIF11NOS2NOS1NOS3GRIK1 | |
| SCHEMBL29888764 | 1.00 | KIF11 (0.42) | KIF11NOS2NOS1NOS3GRIK1 | |
| SCHEMBL12438549 | 0.82 | KIF11 (0.46) | KIF11NOS2NOS1NOS3GRIK1 | |
| SCHEMBL222325 | 0.82 | KIF11 (0.46) | KIF11NOS2NOS1NOS3GRIK1 | |
| SCHEMBL441462 | 0.82 | KIF11 (0.46) | KIF11NOS2NOS1NOS3GRIK1 | |
| Water SCHEMBL6741664 | 0.81 | KIF11 (0.45) | KIF11NOS2NOS1NOS3GRIK1 | |
| Water SCHEMBL6741667 | 0.81 | KIF11 (0.45) | KIF11NOS2NOS1NOS3GRIK1 | |
| Hydrochloric Acid SCHEMBL4744896 | 0.81 | KIF11 (0.45) | KIF11NOS2NOS1NOS3GRIK1 | |
| SCHEMBL18214469 | 0.78 | KIF11 (0.46) | KIF11NOS2NOS1NOS3GRIK1 | |
| SCHEMBL11801814 | 0.78 | KIF11 (0.46) | KIF11NOS2NOS1NOS3GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220089646-A1 | A CYCLIC PEPTIDE | THE UNIVERSITY OF QUEENSLAND (AU) | 2022-03-24 | — | — | US | disclosed |
| WO-2020150788-A1 | A CYCLIC PEPTIDE | THE UNIVERSITY OF QUEENSLAND (AU) | 2020-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089646-A1 | A CYCLIC PEPTIDE | VIP, CALCA, CALCB | KIF11 3428/4885NOS2 1120/4885NOS1 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.